Unique Molecular Subtypes within BCR::ABL1-Postive ALL Show Prognostic Relevance | ASH Clinical News | American Society of Hematology
Khylia Marshall is a freelance journalist based in Tucson, Arizona. Researchers have developed a predictive model for systematically subclassifying BCR::ABL1 -positive acute lymphoblastic leukemia (ALL) into four unique and distinct biologic and clinically relevant entities, according to a study published in Blood. There are currently two distinct diagnostic entities within BCR::ABL1 -positive ALL: lymphoid only, in which the driver gene fusion BCR::ABL1 is observed only in lymphatic precursors, and